An observational study in Fuchs Endothelial Corneal Dystrophy, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-12.
Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Observational
The prevalence of Fuchs Endothelial Corneal Dystrophy (FECD) varies from 3.7 to 21.6% of adults depending on the population studied (country and age class), the method of diagnosis and the definition adopted. In the absence of available data for France, we analyzed the prevalence of Fuchs Endothelial Corneal Dystrophy (FECD) in a specific sub-population.
The Primary purpose is to Estimate the prevalence of Fuchs' endothelial dystrophy in the French population in dermatology population.
92 studies on the registry are indexed under Fuchs' Endothelial Dystrophy; 27 are open to participants now.
This study's enrollment of 1,200 is above the median of 144 across 26 observational studies indexed under Fuchs' Endothelial Dystrophy.
Browse Fuchs' Endothelial Dystrophy studies →Centre Hospitalier Universitaire de Saint Etienne is the lead sponsor of 597 studies on the registry; 127 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patient with screening of Fuchs endothelial corneal dystrophy will be included.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with screening of Fuchs endothelial corneal dystrophy will be included.
Other: collection of medical data
collection of medical data : Age, Sex, Previous cataract surgery, Cellularity, Dermatological pathology, results of screening of Fuchs endothelial corneal dystrophy by Specular microscopy
Dark spot in specular microscopy
Dark sport or guttae after specular microscopy in parallel with the dermatological consultation
Time frame: Years: 1
Prevalence of Fuchs endothelial corneal dystrophy (FECD) as a function of age
Prevalence of Fuchs endothelial corneal dystrophy (FECD) as a function of age. Data of medical record will be analyzed.
Time frame: Years: 1
Prevalence of Fuchs endothelial corneal dystrophy (FECD) as a function of gender
Prevalence of Fuchs endothelial corneal dystrophy (FECD) as a function of gender. Data of medical record will be analyzed.
Time frame: Years: 1
Correlation between Fuchs endothelial corneal dystrophy (FECD) and skin pathology
Correlation between Fuchs endothelial corneal dystrophy (FECD) and skin pathology. Data of medical record will be analyzed.
Time frame: Years: 1
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2024 to primary completion in Dec 2024, 11 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fuchs' Endothelial Dystrophy →
Centre Hospitalier Universitaire de Saint Etienne →